Wolverine Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Wolverine Asset Management's JAZZ Position: Q3 2026 in Review
Wolverine Asset Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 2,330 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #995.
Wolverine Asset Management first reported a position in JAZZ in Q1 2020 and has held it in 14 quarters since. The position peaked at $1.69M in Q2 2024. 671 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Wolverine Asset Management held 2,330 shares of Jazz Pharmaceuticals worth $539K as of Q3 2026.
- Wolverine Asset Management left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Wolverine Asset Management's portfolio in Q3 2026, its #995 holding.
- Wolverine Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 14 quarters since.
- Wolverine Asset Management's Jazz Pharmaceuticals position peaked at $1.69M in Q2 2024.
- 671 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.